Replies to post #103871 on Quantum Materials Corp. (fka QTMM)

[rodman]

As I was advised the company did not have the resources (legal costs) to launch an uplisting so the decision was made to pursue the long covid Qdot technology! Unfortunately the FDA PMA after the clinical trials is a very lengthy process. Hope we have an FDA consultant in our corner. I am heavily invested so I am encouraged by the shared reply from Amber with IR.
$5-$10+